||ホームページ|What's new|幼稚園|小学校|中学|高校|教養|病院|医学部|薬学部|

Cephalalgia 2000;20

Cephalalgia 2000;20(1):

  • Montagna P: Molecular genetics of migraine headaches: a review. Cephalalgia 2000;20(1):3-14★[重要]片頭痛の分子生物学総説
  • Barbanti P et al. Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia 2000;20(1):15-19★片頭痛とドーパミンの関係
  • Siniatchkin M et al. Are the periodic changes of neurophysiological parameters during the pain-free interval in migraine related to abnormal orienting activity? Cephalalgia 2000;20(1):20-29★CNV
  • Geraud G et al. Comparison of the efficacy of zolmitriptan and sumatriptan:issues in migraine trial design. Cephalalgia 2000;20(1):30-38★トリプタン
  • Boska MD et al. Effects of the anti-migraine drug sumatriptan on muscle energy metabolism: relationship to side-effects. Cephalalgia 2000;20(1):39-44★スマトリプタンは筋肉の血流に影響
  • Werhahn KJ et al. Motor cortex excitability in patients with migraine with aura and hemiplegic migraine. Cephalalgia 2000;20(1):45-50★運動皮質の過興奮性なし
  • Aguirre J et al. Cluster of MMPI personality profiles in chronic tension-type headache and predictable response to Fluoxetine. Cephalalgia 2000;20(1):51-56★慢性緊張型頭痛に二つのクラスターがある。SSRIの反応差なし。
  • Wilkinson F, Crotogino J. Orientation discrimination thresholds in migraine: a measure of visual cortical inhibition. Cephalalgia 2000;20(1):57-66★片頭痛の視覚機能。
  • Morales-Asfn F et al. A SUNCT case with response to surgical treatment. Cephalalgia 2000;20(1):67-68★経皮的三叉神経核圧迫が奏効

Cephalalgia 2000;20（2）

  • McColl SL, Wilkinson F: Visual contrast gain control in migraine: measures of visual cortical excitability and inhibition. Cephalalgia 2000;20:74-84　[片頭痛、視覚過興奮性]
  • Costa A et al. The effect of intranasal cocaine and lidocaine on nitroglycerin-induced attacks in cluster headache. Cephalalgia 2000;20:85-91　[群発頭痛にコカイン、リドカイン有効。二重盲検]
  • Read et al. SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat. Cephalalgia 2000;20:92-99　[遺伝子に規定される閾値または環境ストレス→ＳＤ→NO、拡張→TGN賦活→痛覚過敏。SB-220453はＳＤ後のＮＯ遊離を抑えて片頭痛に有効]
  • Stirparo G et al. Linked activation of nitric oxide synthase and cyclooxygenase in peripheral monocytes of asymptomatic migraine without aura patients. Cephalalgia 2000;20:100-106 ［片頭痛、ＮＯ］
  • Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000;20:107-113　「鎮痛薬誘発性慢性連日性頭痛にプレドニゾロンがよい」
  • Kemper RHA et al. Intracistemal octreotide does not ameliorate orthodromic trigeminovascular nociception. Cephalalgia 2000;20:114-121　「octreotide、動物実験」
  • Luciani R et al. Prevention of migraine during prodrome with naratriptan. Cephalalgia 2000;20:122-126　「ナラトリプタンは片頭痛の予防効果あ」
  • Wingerchuk DM et al. Extratrigeminal short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT): new pathophysiologic entity or variation on a theme? Cephalalgia 2000;20:127-129 {cranial-autonomic cephalalgiaなる概念が適当}
  • Peres MFP, Zukerman E: Hemicrania continua responsive to rofecoxib. Cephalalgia 2000;20:130-131
  • Sturm JW, Macdonell R. Recurrent thunderclap headache associated with reversible intracerebral vasospasm causing stroke. Cephalalgia 2000;20:132-135 「雷鳴頭痛」

Cephalalgia 2000;20（2）

  • Cephalalgia 2000;20:3はoral contraceptives (OCs) and hormone replacement therapy (HRT)の特集
  • ●Silberstein SD, Merriam SD. Physiology of the menstrual cycle. Cephalalgia 2000;20:148-54[まとめThe primary trigger of menstrual migraine appears to be the withdrawal of oestrogen rather than the maintenance of sustained high or low oestrogen levels.　Headaches that occur with premenstrual syndrome appear to be centrally generated, involving the inherent rhythm of CNS neurons, including perhaps the serotonergic pain-modulating systems.]
  • ●●Task force:M-G Bousser et al Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. Cephalalgia 2000;20:155-156
    片頭痛女性におけるピル、ホルモン補充療法に関する見解。
  • MacGregor EA, Lignieres B de. The place of combined oral contraceptives in contraception. Cephalalgia 2000;20:157-63
  • Lignieres B de, MacGregor EA. Risks and benefits of hormone replacement therapy. Cephalalgia 2000;20:164-169
  • Massiou M, MacGregor EA. Evolution and treatment of migraine with oral contraceptives. Cephalalgia 2000;20:170-4
  • Conard J, Samama SS. Oral contraceptives, hormone replacement therapy and haemostasis Cephalalgia 2000;20:175-182
  • Bousser M-G, Kittner SJ. Oral contraceptives and stroke. Cephalalgia 2000;20:183-189
  • Tzourio C, Kittner SJ, Bousser M-G, Alperovitch A. Migraine and stroke in young women. Cephalalgia 2000;20:190-9
  • Lignieres B de, Silberstein S: Pharmacodynamics of oestrogens and progestogens. Cephalalgia 2000;20:200-207
  • Kittner SJ, Bousser M-G. Post-menopausal hormone replacement therapy and stroke risk. Cephalalgia 2000;20:208-213
  • Silberstein SD, Lignieres B de: Migraine, menopause and hormonal replacement therapy. Cephalalgia 2000;20:214-221

Cephalalgia 2000;20（4）

  • Pinessi L et al. Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients. Cephalalgia 2000;20:223-227
  • Podoll K, Robinson D: Illusory splitting as visual aura symptom in migraine. Cephalalgia 2000;20:228-232
  • Kelistein DE et al. Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia 2000;20:233-243
  • Hagen K et al. Validity and reliability of a headache questionnaire in a large population-based study in Norway. Cephalalgia 2000;20:243-251
  • Ahmed F: Clinical correspondence: Chronic cluster headache responding to gabapentin: a case report. Cephalalgia 2000;20:252-253
  • Haan J, Ferrari MD: Letters to the Editor: Mahler's Migraine. Cephalalgia 2000;20:254
  • Tfelt-Hansen P: Letters to the Editor: A comment on time-to-event analysis for headache relief. Cephalalgia 2000;20:255
  • Headache World 2000 Abstracts. Cephalalgia 2000;20:261-434Cephalalgia 2000;20(5)

Cephalalgia 2000;20（5）

  • Christiansen I, Iversen HK, Olesen J. Headache characteristics during the development of tolerance to nitrates: pathophysiological implications. Cephalalgia 2000;20:437-44 [NO]
  • Christiansen I, Iversen HK, Olesen J. Induction of nitrate tolerance is not a useful treatment in cluster headache. Cephalalgia 2000;20:445-54 [NO、群発頭痛]
  • Pascual J et al. Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Cephalalgia 2000;20:455-461 {トリプタン}
  • Roon KI et al. The influence of ergotamin abuse on psychological and cognitive functioning. Cephalalgia 2000;20:462-469　[エルゴタミン嗜癖は精神的な影響大、しかし認知機能への障害なし]
  • Heywood J et al. Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year. Cephalalgia 2000;20:470-74　「ナラトリプタンの通年効果」
  • Pira FL et al. Memory disturbances in migraine with and without aura: a strategy problem?. Cephalalgia 2000;20:475-78　「片頭痛と記憶障害の関係」
  • Lu S-R et al. Migraine prevalence in adolescents aged 13-15: a student population-based study in Taiwan. Cephalalgia 2000;20:479-85 「台湾の中学生の片頭痛は6.8％」
  • Bendtsen L. Central sensitization in tension-type headache-possible pathophysiological mechanisms. Cephalalgia 2000;20:486-508　「慢性緊張型頭痛の病因論
  • Dodick DW. Recurrent short-lasting headache associated with paroxysmal hypertension: a clonidine-responsive syndrome. Cephalalgia 2000;20:509-14　「頭痛を伴う突発的な頭痛にたいするクロニジン有効例」
  • Graff-Radford SB. SUNCT syndrome responsive to gabapentin (Neurontin). Cephalalgia 2000;20:515-17　「SUNCT に gabapentin有効」
  • Ertsey C, Jelencsik I: Cough headache associated with Chiari type-I malfon-nation: responsiveness to indometacin. Cephalalgia 2000;20:518-20　「キアリ奇形に伴う咳頭痛にインドメタシン有効」

Cephalalgia 2000;20(6):

  • サプリメントはリザトリプタンの特集
    Rizatriptan: A new milestone in migraine treatment. Cephalalgia 2000;20(Supp1)
  • Palmer JE et al. Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients. Cephalalgia 2000;20(6):525-32/ 前兆片頭痛患者での皮質の興奮性亢進は皮質内抑制過程抑制の結果
  • Leniger T et al. Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells-implication for their potency in migraine therapy. Cephalalgia 2000;20(6):533-7/バルプロ酸、gabapentinの片頭痛への応用(基礎)
  • MaassenVanDenBrink A et al. The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan. Cephalalgia 2000;20(6):538-45./ benzopyran誘導体SB-220453の心毒性
  • Smith M et al. Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453. Cephalalgia 2000;20(6):546-53. /benzopyran誘導体SB-220453は拡延性抑制を抑える。
  • Davies GM et al. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000;20(6):554-60./ 2時間以内に疼痛が寛解すると満足度が高い。
  • ★Gasbarrini A et al. Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura. Cephalalgia 2000;20(6):561-565/.ピロリ菌と片頭痛
  • Wang S-J et al. Prevalence of migraine in Taipei, Taiwan: a population-based survey. Cephalalgia 2000;20(6):566-572./台北の片頭痛頻度は9.1% (F/M 14.4%/4.5%).
  • Hernandez-Latorre MA Roig M. Natural history of migraine in childhood. Cephalalgia 2000;20(6):573-579.早期発症は、芳しくない経過を示す。
  • Aaltonen K et al. Migraine attacks and sleep in children. Cephalalgia 2000;20(6):580-4./若年ほど睡眠寛解率高い。
  • Klapper JA, O'Connor S. Rizatriptan wafer-sublingual vs. placebo at the onset of acute migraine. Cephalalgia 2000;20(6):585-7. /Rizatriptanウェハーの効果検討
  • Pascual J et al. Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study. Cephalalgia 2000;20(6):588-96. / almotriptanの治験
  • Diamond S et al. Intranasal civamide for the acute treatment of migraine headache. Cephalalgia 2000;20(6):597-602.　/鼻腔内投与のCivamide（カルシウムチャネル遮断薬）は片頭痛の急性期治療に有効。
  • L Bendtsen; R Jensen. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000;20(6):603-10. amitriptylineの慢性緊張型頭痛に対する効果は、筋筋膜組織からの疼痛遮断作用も関与している(30％ほど閾値を上げている)。

Cephalalgia 2000;20:7

  • Original articles
  • 611 K Zebenholzer et al. Migrainous disorder and headache of the tension-type not fulfilling the criteria: a follow-up study in children and adolescents
    「小児慢性頭痛の追跡調査。1.7頭痛と2.3頭痛は80％以上オーバラップがある」
  • 617 A Cano et al. Migraine without aura and migrainous disorder in children; International Headache Society (IHS) and revised IHS criteria
    「小児「前兆を伴わない片頭痛」の定義改定案。(1) 持続を最低１時間に引き下げる、(2)両前頭部頭痛の認容、(3) 音過敏、光過敏の一方のみでよい
    以上の改訂で、片頭痛と診断率は39％から、52％へ、1.7片頭痛と診断されるものは20％から７％へ減少した。
  • 621 K Grosser et al. et al. Olfactory and trigeminal event-related potentials in migraine 「嗅神経誘発電位の有用性」
  • 632 A R White et al. Acupuncture for episodic tension-type headache: a multicentre randomized controlled trial　「緊張型頭痛の治療に対する鍼治療のネガティブデータ」
  • 638 G L Lipchik et al. Exteroceptive suppression periods and pericranial muscle tenderness in chronic tension-type headache: effects of psychopathology, chronicity and disability　「慢性緊張型頭痛のES2について」
  • 647 G Sandrini et al. Asynmmetrical reduction of the nociceptive flexion reflex threshold in cluster headache 「群発頭痛は疼痛制御系に異常あり」
  • 653 C Sj6strand et al. A follow-up study of 60 patients after an assumed first period of cluster headache {初回群発頭痛患者の追跡調査。患者によっては１回のみの群発頭痛期間を持つのみ。われわれのケースではわずか17％が３年後に２回目の群発頭痛期を持つのみ}
  • 658 P Linton-Dahlof, M Linde, C Dahl6f: Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study　「慢性連日性頭痛の断薬療法：慢性連日性頭痛の１/４は断薬に反応しない」
  • 663 R Lange, J A Schwarz, M Hohn: Acetylsalicylic acid effervescent 1000 mg (Aspiring) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study　「片頭痛に対する発泡アセチル酸有効率は55.0％：プラセボ36.8％」
  • Historical section
  • 668 J M S Pearce: Samuel-Auguste Tissot (1728-1797) and migraine Clinical correspondence
  • 671 A H Lain et al. SUNCT syndrome; absence of refractory periods and modulation of attack duration by lengthening of the trigger stimuli
  • 674 S Forderreuther et al. Partial improvement of headache in a patient with spontaneous cervical cerebrospinal fluid (CSF) leakage after lumbar blood patch
  • Letters to the Editor
  • 677 S Evers: Peripheral autonomic potentials in different types of headache
  • 678 R Ferrari: Muscle dysfunction in cervical headache

Cephalalgia 2000;20(8)

  • Editorial commentary
    • 685 J W Lance: Is alternating hemiplegia of childhood (AHC) a variant of migraine?Editorial
    • comment
    • 686 M Ferrari, J Haan: Migraine aura, illusory vertical splitting, and Picasso
  • Original articles
  • 687 KMA Welch, NT Mathew, P Stone, W Rosamond, J Saiers, D Gutterman: Tolerability of sumatriptan: clinical trials and post-marketing experience /スマトリプタン
  • 696 J Haan, et al. Alternating hemiplegia of childhood: no mutations in the familial hemiplegic migraine CACNALA gene　/小児交代性片麻痺性
  • ★701 F Granella, G Sances, E Pucci, R E Nappi, N Ghiotto, G Nappi: Migraine with aura and reproductive life events: a case control study　/前兆片頭痛（MA）と非前兆片頭痛（MO）の比較。月経誘発片頭痛の頻度はMA15.0%、MO53.5%、（OR 0.1）、月経前症候群はMAに多い（OR 6.0）、妊娠による改善、MA:MO 43.6%:76.8% （OR 0.2） ピルによる悪化:MA:MO 56.4:25.3 （OR3.8）
  • 708 E Conlon, T Hine: The influence of pattern interference on performance in migraine and visual discomfort groups /片頭痛と視覚の関係
  • 714 A Judit, P S Sindor, J Schoenen: Habituation of visual and intensity dependence of auditory evoked cortical potentials tend to normalize just before and during the migraine attack　/片頭痛と誘発電位
  • ★★720 P Barbanti, G Fabbrini, N Vanacore, A Rum, G L Lenzi, G Meco, R Cerbo: Dopamine and migraine: does Parkinson's disease modify migraine course? /片頭痛率は47.0%：68.2%(OR 0.41)。パーキンソン病の2/3は発病後片頭痛が改善
  • 724 EM Laska, C Siegel: Assessing the onset of relief of a treatment for migraine　/片頭痛効果判定
  • 732 D Millson, M Frischer, P Croft, P Goadsby: Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?　/トリプタン使用とうつの関係。片頭痛患者においてより新しいトリプタンはうつ病のリスクが増加しない
  • 738 C Lampl, K Yazdi, A Buzath, D Klingler:Migraine-like headache in bacterial meningitis /髄膜炎頭痛にスマトリプタンは有効でなかった。
  • 740 A Gorji, D Scheller, F Tegtmeier, R Koehling, H Straub, E J Speckmann: NiCl2 and amiloride induce spreading depression in guinea pig hippocampal slices　/拡延性抑制
  • Letter to the Editor
    • 748 A Krymchantowski: Prednisone as initial treatment of drug-induced daily headache
  • Cephalalgia　Volume 20 Issue s1; October 2000 リザトリプタンの特集
    • 1 Rizatriptan: a new milestone in migraine treatment. Introduction MD Ferrari
    • 2 Pharmacology and potential mechanisms of action of rizatriptan RJ Hargreaves
    • 10 Rizatriptan in acute treatment of migraine: update on new comparative data PJ Goadsby
    • 16 Safety and tolerability of rizatriptan F Sakai
    • 19 Rizatriptan: a new milestone in migraine treatment. Closing remarks J Pascual
  • Cephalalgia　Volume 20 Issue s2; October 2000　治験の方法の特集
    • 1 The challenge of evidence-based migraine therapy Wj Becker
    • 5 Evidence-based migraine therapy: learning needs and knowledge assessment Ra Purdy
    • 10 The principles of evidence-based medicine S Wiebe
    • 14 Acute migraine treatment outcome measures: a clinician's view Fd Sheftell; Aw Fox
    • 25 Drug comparisons: why are they so difficult? R Salonen
    • 33 Evidence-based analysis of a migraine treatment drug comparison trial M Gawel; S Wiebe

Cephalalgia 2000;20(9):765-849

  • Original articles
  • 765 P Tfelt-Hansen, et al: Guidelines for controlled trials of drugs in migraine: second edition /片頭痛治験ガイドライン
  • 787 DW Dodick, TD Rozen, PJ Goadsby, SD Silberstein: Cluster headache　★群発頭痛総説
  • 804 T Sand, J Vanagaite Vingen: Visual, long-latency auditory and brainstem auditory evoked potentials in migraine: relation to pattern size, stimulus intensity, sound and light discomfort thresholds and pre-attack state　/片頭痛、誘発電位
  • 821 V Ulrich, J Olesen, M Gervil, MB Russell: Possible risk factors and precipitants for migraine with aura in discordant twin-pairs: a population-based study　/片頭痛リスク、双生児研究
  • 826 P Torelli, D Cologno, C Cademartiri, G C Manzoni: Primary and secondary chronic cluster headache: two separate entities?　★原発性慢性群発頭痛と続発性慢性群発頭痛は同じか。違う。前者はヘビースモーカーが多く、後者はコーヒー、アルコール耽溺がある。
  • 830 EJ Dasbach, et al: Work and productivity loss in the rizatriptan multiple attack study　/リザトリプタン
  • 835 H Walach et al: The long-term effects of homeopathic treatment of chronic
    headaches: 1 year follow up /ホメオパパシー療法は30％に有用
  • 838 CT Eltorp, I Jansen-Olesen, A j Hansen: Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide　/実験モデル、スマトリプタン、NO
    Clinical correspondence
  • 845 M Leone, et al. Two new SUNCT cases responsive to lamorigine/SUNCT、lamorigine(抗てんかん薬)

Cephalalgia 2000;20(１０):854-

  • Review 　854 Opioids 　Sd Silberstein; Dc McCrory 　【総説、オピオイド】
  • Original Articles
  • 865 Visual contrast processing in migraine
    Aj Shepherd 【片頭痛発作の視覚パターンへの反応に関する研究】
  • 881 Slow cortical potentials in migraine families
    M Siniatchkin; E Kirsch; P Kropp; U Stephani; W-D Gerber
    【随伴陰性変動の早期コンポーネントの馴化が片頭痛を特徴づける】
  • 893 The prevalence of migraine in women aged 40-74 years: a population-based study
    P Mattsson; K Svardsudd; Po Lundberg; C-E Westerberg
    【40〜74歳女性の疫学調査。片頭痛の生涯有病率は31.5、年間有病率は18.0%。片頭痛視覚前兆の有病率は3.8%。片頭痛の年齢性有病率低下は疼痛の強さの減少に起因する】
  • 900 Prevalence of migraine and non-migrainous headache・/mdash>head-HUNT, a large population-based study
    K Hagen; J-A Zwart; L Vatten; Lj Stovner; G Bovim
    【ノルウェー51383人の頭痛調査。1年の有病率は38%。片頭痛の有病率は12%（女性16%、男性8%）。非片頭痛様頭痛26%頻。頻繁頭痛（1ヵ月につき6日以上）8%、慢性頭痛（1ヵ月につき14日）2%。30台が頭痛のピーク】
  • 907 Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks
    P Sarchielli; A Alberti; M Codini; A Floridi; V Gallai
    【片頭痛発作中内頸静脈の亜硝酸塩（NOの安定代謝産物）、CGRP、NKA、PGE2などを調べた。片頭痛発作中一酸化窒素（NO）生産の内因性の増加に肯定的研究結果を得た】
  • 919 Possible mechanisms of glyceryl-trinitrate-induced immediate headache in patients with chronic tension-type headache
    M Ashina; L Bendtsen; R Jensen; F Sakai; J Olesen
    【NOドナー・ニトログリセリン（GTN）の慢性緊張型頭痛患者において、GTN注入は、即時の頭痛及び遅延性頭痛を起こした。しかし頭痛周囲筋の圧痛等増さなかった】
  • 925 A prospective study of migraine with aura attacks in a headache clinic population
    D Cologno; P Torelli; C Cademartiri; Gc Manzoni
    【片頭痛前兆の追跡調査】
  • Clinical Correspondence
  • 931 Radiotherapy in a case of Tolosa-Hunt syndrome
    E Mormont; P Laloux; J Vauthier; M Ossemann
    【トロサ・ハント症候群に放射線療法有効】